Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2022-02-25

New medicine for rare type of eye cancer

View source ↗

Summary

The EMA announces a new medicine addressing a rare eye cancer, marking an important regulatory milestone for an orphan indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications